Table 5. Univariate and multivariable analyses for the risk factors of mitral valve related events.
Variablesa | Univariate analysis | PS-adjusted multivariable analysis | |||
---|---|---|---|---|---|
HR [95% CI] | P value | HR [95% CI] | P value | ||
Types of valves | 1.180 [0.829–1.679] | 0.36 | 1.498 [0.975–2.301] | 0.065 | |
Body surface area (m2) | 0.324 [0.105–0.996] | 0.049 | 0.357 [0.103–1.235] | 0.10 | |
Diabetes mellitus | 1.473 [1.013–2.140] | 0.042 | 0.999 [0.645–1.549] | 0.99 | |
COPD | 0.453 [0.202–1.016] | 0.055 | 0.455 [0.192–1.077] | 0.073 | |
Coronary artery disease | 1.786 [1.118–2.853] | 0.015 | 1.477 [0.923–2.365] | 0.10 | |
NYHA class ≥3 | 1.837 [1.345–2.509] | <0.001 | 1.517 [1.088–2.117] | 0.014 | |
Previous MVR | 1.702 [1.141–2.538] | 0.009 | 1.069 [0.682–1.677] | 0.77 | |
Euroscore II | 1.098 [1.062–1.135] | <0.001 | 1.082 [1.040–1.125] | <0.001 | |
Arrhythmia surgery | 0.658 [0.477–0.909] | 0.011 | 0.771 [0.536–1.107] | 0.16 |
a, all variables in Table 1 were analyzed and factors that entered into the multivariable analysis were shown. CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; NYHA, New York Heart Association; MVR, mitral valve replacement; PS, propensity score.